Related Experiment Videos
[Regional differences in drug use in relation to the causes]
B Idzior-Waluś1, A Kuźmińska, J Sznajd
1Katedry Diagnostyki Biochemicznej i Kliniki Chorób Metabolicznych Akademii Medycznej w Krakowie.
Summary
Drug use for coronary disease and hypertension is significantly higher in Warsaw compared to Tarnobrzeg province. This study highlights regional disparities in cardiovascular medication prescribing patterns.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Cardiovascular diseases, including coronary heart disease and hypertension, are major public health concerns.
- Medication adherence and prescribing patterns can vary significantly based on geographical location and socioeconomic factors.
- Understanding regional drug utilization is crucial for optimizing cardiovascular disease management.
Purpose of the Study:
- To compare the patterns of drug use for coronary heart disease and hypertension between Warsaw and Tarnobrzeg province.
- To identify differences in the types and frequency of medications prescribed for cardiovascular conditions in two distinct Polish regions.
Main Methods:
- A population-based study involving a random sample of men and women aged 35-64 years from Warsaw and Tarnobrzeg province.
- Data collection aligned with the POL-MONICA studies methodology.
- Analysis of drug utilization, including specific drug classes and daily defined doses (DDD/1000 inhabitants/day).
Main Results:
- Overall drug use was higher in Warsaw (23%) compared to Tarnobrzeg province (12.1%).
- Drug use for coronary heart disease was 4.5-fold higher in Warsaw, with nitrates, curantyl, and beta-blockers being most common.
- Hypotensive drug use in Warsaw was double that in Tarnobrzeg province, despite similar hypertension prevalence, with significant regional differences observed in women's drug choices.
Conclusions:
- Significant regional disparities exist in the utilization of medications for coronary heart disease and hypertension between Warsaw and Tarnobrzeg province.
- Prescribing patterns for cardiovascular conditions differ notably, suggesting potential variations in treatment guidelines or access to care.
- Further research is warranted to explore the underlying reasons for these observed geographical differences in drug use.